Raifeld Pavel 4

What Happened

• Pavel Raifeld, CEO of Innoviva, was granted equity awards on May 4, 2026: 126,646 restricted stock units (RSUs) and 312,500 derivative awards (non‑statutory stock options), each reported at an acquisition price of $0.00 (standard for awards). These are awards/conditional grants rather than open‑market purchases or sales.

Key Details

• Transaction date: May 4, 2026; Form 4 filed May 6, 2026.
• Award amounts and prices: 126,646 RSUs @ $0.00 (acquired); 312,500 derivative awards @ $0.00 (acquired).
• Shares owned after transaction: Not disclosed in this filing.
• Grant condition: Awards were granted subject to stockholder approval of Innoviva’s 2026 Equity Incentive Plan (per the Form 14A disclosure).
• Vesting: 25% of each grant vests on February 20, 2027; the remaining balance vests in twelve substantially equal installments every three months thereafter, subject to continuous service.
• Acceleration: Options accelerate in certain "change in control" scenarios if not assumed/replaced (provided no prior termination); both Options and RSUs may accelerate on an involuntary termination within 24 months after a change in control if assumed/substituted, subject to a release of claims.
• Filing timeliness: Form 4 was filed two days after the reported grants (May 6 vs. May 4), which is within the typical Form 4 reporting window.

Context

• These entries are awards (code A) — a compensation grant, not an open‑market buy or sale. The derivative line reflects stock options (non‑statutory) per the footnotes; options themselves are not exercised here. Awards reported at $0.00 indicate grants rather than cash purchases. Such grants are common for executive compensation and subject to vesting and company/stockholder approvals.